Technology Insight: vaccine therapy for prostate cancer

Related Experiment Video

Updated: Aug 11, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Johannes Vieweg1, Jens Dannull

  • 1Duke University Medical Center, Durham, North Carolina 27710, USA. j.vieweg@duke.edu

Nature Clinical Practice. Urology
|February 14, 2006
PubMed

Insights

Developing novel prostate cancer vaccines is crucial due to limited effective therapies. These immune-based strategies aim to control cancer with minimal toxicity by targeting tumor antigens.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Advanced prostate cancer lacks effective treatments, necessitating novel therapeutic approaches.
  • Recent advances in understanding immune regulation and cancer biology have spurred the development of immune-based strategies.
  • Cancer vaccines offer a promising targeted therapy with the potential for reduced toxicity.

Purpose of the Study:

  • To review current vaccine-based strategies for advanced prostate cancer therapy.
  • To discuss the mechanisms of action for various prostate cancer vaccine approaches.
  • To present relevant clinical trial data on the efficacy and safety of these vaccines.

Main Methods:

  • Overview of different vaccination strategies including peptide, DNA, dendritic cell, tumor cell, and viral vector-based vaccines.
  • Discussion of the immunological principles underlying these strategies, focusing on eliciting anti-tumor immune responses.
  • Analysis of clinical trial outcomes for various prostate cancer vaccines in development.

Main Results:

  • Multiple prostate cancer vaccine candidates are in various stages of clinical development.
  • Vaccination strategies aim to stimulate immune responses against prostate tumor-associated antigens.
  • Understanding immune modulation is key to optimizing vaccine efficacy.

Conclusions:

  • Vaccine-based strategies represent a promising avenue for advanced prostate cancer treatment.
  • Further research into the mechanisms of immune response modulation is essential for therapeutic success.
  • Clinical trials are vital for evaluating the potential of these novel immunotherapies.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.